World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XI – Milk supplement/replacement formulas for infants and toddlers with CMA – Systematic review

Currently available studies comparing eHF-CM, AAF, HRF, and SF provide very low certainty evidence about their effects in infants with IgE-mediated and non-IgE-mediated CMA. Our review revealed several limitations in the current body of evidence, primarily arising from concerns related to the quality of studies, the limited size of the participant populations and most importantly the lack of diversity and standardization in the compared interventions. It is therefore imperative for future studies to be methodologically rigorous and investigate a broader spectrum of available interventions. We encourage clinicians and researchers to review current World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines for suggestions on how to use milk replacement formulas in clinical practice and what additional research would be the most beneficial.

Authors

Institutions

Publication Details

Journal
World Allergy Organization Journal
Published
2024-09-01
DOI
https://doi.org/10.1016/j.waojou.2024.100947
Citations
8
Primary Topic
Food Allergy and Anaphylaxis Research
Type
article
Field-Weighted Citation Impact
3.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XI – Milk supplement/replacement formulas for infants and toddlers with CMA – Systematic review

Gideon Lack, Arnav Agarwal, Lamia Dahdah, Jan Brożek et al.
8 citations
World Allergy Organization Journal
Food Allergy and Anaphylaxis Research
3.06
article

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XI – Milk supplement/replacement formulas for infants and toddlers with CMA – Systematic review

Gideon Lack, Arnav Agarwal, Lamia Dahdah, Jan Brożek, Siw Waffenschmidt, Rose Kamenwa, Carina Venter, Elena Galli, Ruby Pawankar, Luigi Terracciano, Ignacio Javier Ansotegui, Yvan Vandenplas, Hania Szajewska, Alberto M. Martelli, Piotr Dziechciarz, Amal Assa’ad, Jonathan M. Spergel, Yetiani Roldán, Susan Waserman, Antonio Bognanni, Raanan Shamir, Anna Nowak‐Węgrzyn, Andrea Horvath, Motohiro Ebisawa, Alessandro Fiocchi, Ramon Targino Firmino, Hanako Mihara, Stefania Arasi, Holger J. Schünemann, Gary Wong, Christophe Dupont, Derek K. Chu, Martín Bózzola, Maria Said, Sami L. Bahna, Nikolaos G. Papadopoulos, A. Chu, Anna Starok, Haiqi Li, Amena Warner
article en
8 citations

Abstract

Currently available studies comparing eHF-CM, AAF, HRF, and SF provide very low certainty evidence about their effects in infants with IgE-mediated and non-IgE-mediated CMA. Our review revealed several limitations in the current body of evidence, primarily arising from concerns related to the quality of studies, the limited size of the participant populations and most importantly the lack of diversity and standardization in the compared interventions. It is therefore imperative for future studies to be methodologically rigorous and investigate a broader spectrum of available interventions. We encourage clinicians and researchers to review current World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines for suggestions on how to use milk replacement formulas in clinical practice and what additional research would be the most beneficial.

World Allergy Organization JournalVol. 17(9)
Cincinnati Children's Hospital Medical Center (US), Children's Hospital of Philadelphia (US), Humanitas University (IT), Vrije Universiteit Brussel (BE), Chinese University of Hong Kong (HK), King's College London (GB), Guy's and St Thomas' NHS Foundation Trust (GB), National and Kapodistrian University of Athens (GR), Medical University of Warsaw (PL), Aga Khan University Hospital Nairobi (KE), Institute for Quality and Efficiency in Health Care (DE), Universidade Federal de Campina Grande (BR), Children's Hospital Colorado (US), Space Research Institute (UA), ENT and Allergy (US), Aga Khan University Nairobi (KE), Fatebenefratelli Hospital (IT), Italian Society of Physiotherapy (IT), Schneider Children's Medical Center (IL), Hospital Quirónsalud Barcelona (ES), National Sagamihara Hospital (JP), Modern Water (United Kingdom) (GB), Bambino Gesù Children's Hospital (IT), Institut Marcel Mauss (FR), Belgian Health Care Knowledge Centre (KCE) (BE), Lukasiewicz Research Network - Krakow Institute of Technology (PL), Hospital Británico de Buenos Aires (AR), Nippon Medical School Hospital (JP), Children's Hospital of Chongqing Medical University (CN), Impact (CA), University of Warmia and Mazury in Olsztyn (PL), New York University (US), University of Pennsylvania (US), Nippon Medical School (JP), Louisiana State University Health Sciences Center Shreveport (US), Chongqing Medical University (CN), University of Colorado Denver (US), McMaster University (CA)
Amgen, Pfizer, AstraZeneca, Sanofi, Mead Johnson Nutrition, Danone, CSL Behring, Regeneron Pharmaceuticals, BioCryst, Aimmune Therapeutics, Mylan, Action Medical Research, Bausch Health, Food Allergy Canada, National Institutes of Health, Medical Research Council
Zero hunger
Openalex Percentile: Top 8%
Food Allergy and Anaphylaxis Research
3.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.